Trending...
- Chicago: Mayor Brandon Johnson Welcomes Metropolitan Mayors Caucus, Builds on Bipartisan Coalition That Held the Line on Local Government Funding
- Cress Creeks Farm Opens Fall Corn Maze and Baby Lamb Hayride Experience in Ellijay, Georgia
- WCIA 3's Kevin Lighty to Interview Aerostratospheric President Jeremy Higgs on Behind the Forecast
SAN FRANCISCO - illiNews -- Nuevozen a healthcare Artificial Intelligence company developing patient risk assessment and diagnostic solutions for cancer and other serious diseases, is pleased to announce the addition of Dr. Victor Levin, a leading Neuro Oncologist in the world, to the company's medical advisory board.
Currently, Dr. Levin is a Neuro-Oncology Physician in the Department of Neurosurgery and Neuroscience, Kaiser Permanente Medical Center, Redwood City. He is also Professor Emeritus, Department of Neuro-Oncology, The University of Texas M. D. Anderson Cancer Center and Clinical Professor, Department of Neurosurgery, at UCSF School of Medicine. He built and chaired the world-renowned Neuro-Oncology program at the University of Texas M. D. Anderson Cancer Center.
I am deeply honored and excited to have Dr. Levin, one of the leading experts in the field of neuro-oncology, join our advisory board," stated Karan Aujla, Nuevozen' co-founder and CEO. "I look forward to working with Dr Levin to leverage his knowledge and expertise and his passion for improving patient outcome to help our team identify and develop clinical use cases of AI including volumetric analysis of infiltrative CNS tumors seen with MRI".
More on illi News
"I'm excited to join Nuevozen' advisory board and look forward to helping guide the company as they continue to develop their Artificial Intelligence technology," said Dr. Victor Levin. "I believe that Artificial Intelligence has the potential to improve the diagnosis of infiltrative CNS tumors and metastases and to quantify benefit of new drug therapies and other treatments for CNS tumors"
Dr. Levin founded the Society for Neuro-Oncology in 1995 and served as its first president in 1996. He has published nearly 400 peer-reviewed articles, chapters, editorials, and books including the multidisciplinary textbook, Cancer in the Nervous System. In his career, Dr. Levin received numerous awards including the Anne and Jason Farber Award for Neuro-Oncology, Gold Medal Award for Extraordinary Achievement (Society for Neuro-Oncology). He has also been listed in The Best Doctors in America, America's Top Doctors in Cancer, and America's Top Doctors for many years.
About Nuevozen Corp.
Founded in 2018, Nuevozen Corp. is a privately held Healthcare AI company located in San Francisco Bay area. Nuevozen' mission is to help healthcare providers in improving quality and speed of care by utilizing artificial intelligence. For additional information go to www.Nuevozen.AI
Currently, Dr. Levin is a Neuro-Oncology Physician in the Department of Neurosurgery and Neuroscience, Kaiser Permanente Medical Center, Redwood City. He is also Professor Emeritus, Department of Neuro-Oncology, The University of Texas M. D. Anderson Cancer Center and Clinical Professor, Department of Neurosurgery, at UCSF School of Medicine. He built and chaired the world-renowned Neuro-Oncology program at the University of Texas M. D. Anderson Cancer Center.
I am deeply honored and excited to have Dr. Levin, one of the leading experts in the field of neuro-oncology, join our advisory board," stated Karan Aujla, Nuevozen' co-founder and CEO. "I look forward to working with Dr Levin to leverage his knowledge and expertise and his passion for improving patient outcome to help our team identify and develop clinical use cases of AI including volumetric analysis of infiltrative CNS tumors seen with MRI".
More on illi News
- Jeron Continues to Invest in Technology to Meet Growing Demands
- Put Your Herd on Your Phone: Kiko Nation Makes Livestock Management Simple
- Future Intelligence Think Tank Surpasses 1,000 Members Exploring Human and Artificial Intelligence
- Gary Bernstein Expands Media Leadership Role With Senior Strategic Advisor Appointment To Blacksun Private Equity
- Litera Brings Foundation Firm AI Search into ChatGPT with Plugin
"I'm excited to join Nuevozen' advisory board and look forward to helping guide the company as they continue to develop their Artificial Intelligence technology," said Dr. Victor Levin. "I believe that Artificial Intelligence has the potential to improve the diagnosis of infiltrative CNS tumors and metastases and to quantify benefit of new drug therapies and other treatments for CNS tumors"
Dr. Levin founded the Society for Neuro-Oncology in 1995 and served as its first president in 1996. He has published nearly 400 peer-reviewed articles, chapters, editorials, and books including the multidisciplinary textbook, Cancer in the Nervous System. In his career, Dr. Levin received numerous awards including the Anne and Jason Farber Award for Neuro-Oncology, Gold Medal Award for Extraordinary Achievement (Society for Neuro-Oncology). He has also been listed in The Best Doctors in America, America's Top Doctors in Cancer, and America's Top Doctors for many years.
About Nuevozen Corp.
Founded in 2018, Nuevozen Corp. is a privately held Healthcare AI company located in San Francisco Bay area. Nuevozen' mission is to help healthcare providers in improving quality and speed of care by utilizing artificial intelligence. For additional information go to www.Nuevozen.AI
Source: Nuevozen
Filed Under: Health
0 Comments
Latest on illi News
- Automated Mud Flap System Offers an Adjustable Approach to Heavy-Duty Vehicle Mud Flap Design
- Chicago: Mayor Brandon Johnson Announces City Has Made More Than $1 Billion in Supplemental Pension Payments Since 2023
- Chicago: Mayor Brandon Johnson, DPD Celebrate Completion of Winnslie Parkway Expansion in Ravenswood
- Chicago: Mayor Brandon Johnson Cuts Ribbon on Boulevard Apartments, Preserving 70 Affordable Homes Across Three Buildings
- Naperville: Structure Fire in the 30W000 Block of Argyll Lane
- Naperville's Annual Public Safety Open House Set for Sept. 26
- Infinity Infusion Solutions Named Finalist for D Magazine's D CEO 2026 Excellence in Healthcare Awards
- Canadian Tint Expo 2027: Why Every Window Tinter Should Compete in Niagara Falls on April 3rd & 4th
- The Drywall Helper Introduces a Versatile Approach to Measuring and Supporting Drywall
- InvisoScreen™ Introduces a New Approach to Window Screening
- Patented Smellavision Concept Aims to Add the Sense of Smell to Gaming and Entertainment
- Crib Notes Introduces an Interactive Approach to Early Alphabet Learning
- Building a Diversified Healthcare Platform as Exosome Science, Telehealth, Diagnostics & Strategic Acquisitions Converge: NexTel Medical (OTCID: MAJI)
- Most Indiana Plane Crashes Happen Away from the State's Major Airports
- L2 Aviation Welcomes Jason Marshall as Vice President of Sales and Business Development
- Mom Era, Still That Girl: Family Art Tees 25% Off
- Fashion vs. Fascism - Because Democracy Should Always Be In Style
- Mayor Brandon Johnson, CDOT, and LYFT Announce Divvy's Busiest Summer Ever as Biking Continues to Boom in Chicago
- Chicago: Mayor Brandon Johnson Announces Appointments to Department of Fleet and Facility Management and Department of Human Resources
- Lee Gunn IV Shares Lessons From 40 Years in the Courtroom on PodNumbra Podcast